MORE LIFE WHILE LIVING Trademark

Trademark Overview


On Wednesday, February 1, 2023, a trademark application was filed for MORE LIFE WHILE LIVING with the United States Patent and Trademark Office. The USPTO has given the MORE LIFE WHILE LIVING trademark a serial number of 97776646. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, July 9, 2024. This trademark is owned by BioNADrx Holdings, Inc.. The MORE LIFE WHILE LIVING trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for humans and animals for purposes of increasing intracellular NAD+ to prevent aging conditions and disorders; Pharmaceutical preparations for humans and animals for use in treating and managing diseases, disorders, and conditions relating to aging; Therapeutic preparations for humans and animals, namely, therapeutic pharmaceutical preparations in the nature of an oral composition of NAD+ for treating and managing NAD deficiency and supplementing coenzyme depletion; Therapeutic pharmaceutical agents for humans and animals for regulation of gene expression in aging and metabolic disease, nutrient sensing, and inflammasome suppression

Research and development in the fields of human and veterinary pharmaceuticals, NAD deficiency, aging, and aging-related diseases, disorders, and conditions for humans and animals; Providing medical scientific information in the fields of human and veterinary pharmaceuticals, NAD deficiency, aging, and aging-related diseases, disorders, and conditions for humans and animals
more life while living

General Information


Serial Number97776646
Word MarkMORE LIFE WHILE LIVING
Filing DateWednesday, February 1, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, July 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 14, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for humans and animals for purposes of increasing intracellular NAD+ to prevent aging conditions and disorders; Pharmaceutical preparations for humans and animals for use in treating and managing diseases, disorders, and conditions relating to aging; Therapeutic preparations for humans and animals, namely, therapeutic pharmaceutical preparations in the nature of an oral composition of NAD+ for treating and managing NAD deficiency and supplementing coenzyme depletion; Therapeutic pharmaceutical agents for humans and animals for regulation of gene expression in aging and metabolic disease, nutrient sensing, and inflammasome suppression
Goods and ServicesResearch and development in the fields of human and veterinary pharmaceuticals, NAD deficiency, aging, and aging-related diseases, disorders, and conditions for humans and animals; Providing medical scientific information in the fields of human and veterinary pharmaceuticals, NAD deficiency, aging, and aging-related diseases, disorders, and conditions for humans and animals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 21, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 21, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBioNADrx Holdings, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJohnson City, TN 37604

Party NameBioNADrx Holdings, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJohnson City, TN 37604

Trademark Events


Event DateEvent Description
Tuesday, February 7, 2023NEW APPLICATION ENTERED
Tuesday, February 21, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 18, 2023ASSIGNED TO EXAMINER
Monday, September 18, 2023NON-FINAL ACTION WRITTEN
Monday, September 18, 2023NON-FINAL ACTION E-MAILED
Monday, September 18, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 14, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, December 14, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, March 18, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 18, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 19, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 5, 2024EXAMINERS AMENDMENT -WRITTEN
Friday, April 5, 2024EXAMINERS AMENDMENT E-MAILED
Friday, April 5, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, April 5, 2024EXAMINER'S AMENDMENT ENTERED
Friday, April 5, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 14, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 9, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 24, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 14, 2024PUBLISHED FOR OPPOSITION
Monday, January 6, 2025SOU TEAS EXTENSION RECEIVED